tiprankstipranks
Ulisse Biomed S.p.A. (DE:8XX)
STUTTGART:8XX

Ulisse Biomed S.p.A. (8XX) Income Statement

0 Followers

Ulisse Biomed S.p.A. Income Statement

Last quarter (Q ), Ulisse Biomed S.p.A.'s total revenue was €―. In Q, Ulisse Biomed S.p.A.'s net income was €―. See Ulisse Biomed S.p.A.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 20Dec 19
Total Revenue
€ ―€ 429.00K€ 11.00K
Cost of Revenue
€ ―€ 229.00K€ 711.00K
Gross Profit
€ ―€ 200.00K€ -700.00K
Operating Expense
€ ―€ 80.00K€ 417.00K
Operating Income
€ ―€ 120.00K€ -1.12M
Net Non Operating Interest Income Expense
€ ―€ 0.00€ 0.00
Other Income Expense
€ ―--
Pretax Income
€ ―€ 224.00K€ -1.10M
Tax Provision
€ ―€ 2.00K€ 0.00
Earnings From Equity Interest Net Of Tax
€ ―--
Net Income Common Stockholders
€ ―€ 222.00K€ -1.10M
Basic EPS
€ ―--
Diluted EPS
€ ―--
Basic Average Shares
€ ―--
Diluted Average Shares
€ ―--
Dividend Per Share
€ ―--
Total Operating Income As Reported
€ ―--
Reported Normalized Basic E P S
€ ―--
Reported Normalized Diluted E P S
€ ―--
Rent Expense Supplemental
€ ―€ 66.00K€ 105.00K
Total Expenses
€ ―€ 309.00K€ 1.13M
Net Income From Continuing And Discontinued Operation
€ ―€ 222.00K€ -1.10M
Normalized Income
€ ―€ 118.93K€ -1.12M
Interest Expense
€ ―€ 0.00€ 0.00
EBIT
€ ―€ 224.00K€ -1.10M
EBITDA
€ ―€ 275.00K€ -1.04M
Currency in EUR

Ulisse Biomed S.p.A. Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis